bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
0.499
-0.014 (-2.65%)
At close: Oct 24, 2024, 4:00 PM
0.500
+0.001 (0.18%)
After-hours: Oct 24, 2024, 5:08 PM EDT
bluebird bio Revenue
bluebird bio had revenue of $16.10M in the quarter ending June 30, 2024, with 133.69% growth. This brings the company's revenue in the last twelve months to $54.90M, up 483.79% year-over-year. In the year 2023, bluebird bio had annual revenue of $29.50M with 720.04% growth.
Revenue (ttm)
$54.90M
Revenue Growth
+483.79%
P/S Ratio
1.43
Revenue / Employee
$146,400
Employees
375
Market Cap
96.78M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
So-Young International | 206.62M |
Agenus | 159.63M |
Assertio Holdings | 132.19M |
FONAR | 102.88M |
DBV Technologies | 13.81M |
BLUE News
- 16 days ago - Bluebird Bio (BLUE) Stock Dips Amid Market Volatility - GuruFocus
- 18 days ago - Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma - Seeking Alpha
- 20 days ago - bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 22 days ago - Bluebird Bio (BLUE) Stock Surges 5.04% Amid Market Movements - GuruFocus
- 27 days ago - bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing - Business Wire
- 4 weeks ago - Bluebird bio to cut 25% of workforce as part of restructuring - Reuters
- 4 weeks ago - bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025 - Business Wire
- 5 weeks ago - bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q - Business Wire